Chemotherapy for Muscle-Invasive Bladder Cancer

Chemotherapy (also called chemo) uses drugs to destroy or damage fast-growing cells like cancer cells. It is used to shrink tumors, slow cancer’s growth, relieve symptoms, or help people live longer. Chemotherapy drugs are given in different ways (intravenously, orally by a pill, or by injection). 

Chemotherapy is most often given before surgery. This is called neoadjuvant (NEE-oh-AD-joo-vant) chemotherapy. Studies show that neoadjuvant therapy before radical cystectomy improves survival. Chemotherapy may also be given after surgery. This is called adjuvant chemotherapy. This is often done to try to kill any cancer that may have spread to other parts of the body.

These are the latest chemotherapy drugs that are approved to treat muscle-invasive bladder cancer. New treatments become available all the time, so this may not be a complete list.

Please note: The side effects listed here do not represent a comprehensive list. It's important to discuss all potential side effects of a drug with your healthcare team. Be sure to tell your healthcare team about any side effects you do have.

All Available Treatments

IV or Injection =
Pill =

Treatment Type

Antitumor Antibiotic

Drug Name
Mutamycin® (mitomycin) (IV)
Important Things to Know

This medication can be given alone or in combination with fluorouracil.  

  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding.
  • Mouth sores are a potential side effect that can be painful and affect your oral intake. Speak to your provider about proactive management and an oral care regimen.
  • When used as intravesical therapy, bladder irritation may occur.

Treatment Type

Antimetabolite

Drug Names
Adrucil® (5-fu or 5-fluorouracil) (IV)
Gemzar® (gemcitabine) (IV)
Otrexup™ (methotrexate) (IV)
Potential Side Effects - Otrexup
Low blood counts Mouth sores Weight/appetite changes
Important Things to Know
  • Adrucil can be given in combination with cisplatin or mitomycin.
  • Adrucil only: Discoloration along the vein could occur with this infusion. If this occurs, discuss it with your health care team so they can evaluate it.
  • Gemzar can be given alone or in combination with paclitaxel.
  • Otrexup is given in the ddMVAC regimen or CMV regimen.
  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding.
  • Mouth sores are a potential side effect of Otrexup that can be painful and affect your oral intake. Speak to your provider about proactive management and an oral care regimen. 

Treatment Type

Anthracycline Antibiotic

Drug Name
Adriamycin® (doxorubicin) (IV)
Important Things to Know
  • This medication is given in the ddMVAC treatment regimen.
  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding. 

Treatment Type

Alkylating Agent

Drug Name
Platinol® (cisplatin) (IV)
Important Things to Know
  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding.
  • This medication is given in the ddMVAC treatment regimen, CMV regimen, or in combination with fluorouracil.
  • Damage to the kidneys is a potential side effect.

Treatment Type

Plant Alkaloid

Drug Names
Alkaban-AQ® (vinblastine) (Pill,IV)
Taxol® (paclitaxel) (Pill,IV)
Potential Side Effects - Alkaban-AQ
Adverse drug reaction Fatigue/weakness Low blood counts
Important Things to Know
  • These medications are given through an IV or as an injection.
  • Alkaban-AQ is given in the ddMVAC regimen or CMV regimen.
  • Taxol is given in combination with gemcitabine.
  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding.
  • Mouth sores are a potential side effect of Taxol that can be painful and affect your oral intake. Speak to your provider about proactive management and an oral care regimen.